Director/PDMR Shareholding

RNS Number : 2743K
GlaxoSmithKline PLC
12 July 2011
 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

 

The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 12 July 2011 of an increase in their notional interests in Ordinary shares at a price of 1366.50 pence per Ordinary share and ADRs at a price of $43.91 per ADR following the notional re-investment of the dividend paid to shareholders on 7 July 2011.

 

 


Ordinary shares

ADRs

Mr A P Witty

16,126.401


Dr M M Slaoui


4,323.445

Mr S M Bicknell

1,434.575


Mr J M Clarke

4,015.251


Mrs D P Connelly


2,544.286

Mr M Dunoyer

1,887.406


Mr E J Gray

3,030.207


Mr S A Hussain

3,961.933


Mr W C Louv


1,304.354

Dr D Pulman


1,954.980

Mr D S Redfern

1,848.253


Mr J R Stéphenne

2,322.273


Ms C Thomas

2,664.210


Mr P C Thomson

215.137


Mr D E Troy


2,580.684

Dr P J T Vallance

2,617.960


Ms E Walmsley

1,557.579


Mrs V A Whyte

215.137


 

 

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

 

12 July 2011

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQLLFFFDFXBBL

Companies

GSK (GSK)
UK 100

Latest directors dealings